108 related articles for article (PubMed ID: 4655110)
1. [Hyaluronidase therapy of progressive scleroderma].
Mahrle G; Herrmann WP; Steigleder GK
Hautarzt; 1972 Jul; 23(7):305-7. PubMed ID: 4655110
[No Abstract] [Full Text] [Related]
2. [Theoretical aspects of the new possibilities of use of hyaluronidase].
Petter O; Bellmann H
Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774
[No Abstract] [Full Text] [Related]
3. [Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase].
Petter O; Bellmann H
Hautarzt; 1971 Jan; 22(1):32-3. PubMed ID: 4251354
[No Abstract] [Full Text] [Related]
4. [Our experience in the treatment of progressive scleroderma with hyaluronidase].
Janković D; Mladenović P; Arnerić S; Stanković K
Srp Arh Celok Lek; 1975 Jun; 103(6):531-4. PubMed ID: 1209350
[No Abstract] [Full Text] [Related]
5. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
6. [Treatment of generalized (progressive) scleroderma].
Balda BR
Dtsch Med Wochenschr; 1972 Dec; 97(48):1876-8. PubMed ID: 4117979
[No Abstract] [Full Text] [Related]
7. [Treatment with hyaluronidase in dermatology].
Wozniak KD; Braun W
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
[No Abstract] [Full Text] [Related]
8. Hyaluronidase Treatment of Scleroderma-Induced Microstomia.
Melvin OG; Hunt KM; Jacobson ES
JAMA Dermatol; 2019 Jul; 155(7):857-859. PubMed ID: 31141116
[No Abstract] [Full Text] [Related]
9. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
Wozniak KD; Braun W
Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
[No Abstract] [Full Text] [Related]
10. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
Neudecker BA; Stern R; Connolly MK
Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
[TBL] [Abstract][Full Text] [Related]
11. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
12. Physiotherapeutic viewpoints in progressive scleroderma.
Callies R; Danz J; Lindau P
Z Gesamte Inn Med; 1976 Jan; 31(2):50-1. PubMed ID: 960891
[TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E1 in progressive systemic scleroderma].
Biltz H; Küster W; Lüders G; Wehrmann W; Kreysel HW
Vasa Suppl; 1988; 23():138-40. PubMed ID: 3206331
[No Abstract] [Full Text] [Related]
14. [1. Progressive scleroderma. 2. Pustular palmo-plantar psoriasis].
Grimmer H
Z Haut Geschlechtskr; 1966 Jun; 40(9):Suppl:lix-lxii. PubMed ID: 5996383
[No Abstract] [Full Text] [Related]
15. [Additional experiences with the ambulatory rehabilitation treatment of infarct patients].
Kiss E; Kubicek F; Polzer K
Wien Med Wochenschr; 1973 Oct; 123(42):622-6. PubMed ID: 4747009
[No Abstract] [Full Text] [Related]
16. Pulse therapy in scleroderma.
Vatwani V; Palta SC; Verma N; Pathak PR; Singh RP
Indian Pediatr; 1994 Aug; 31(8):993-5. PubMed ID: 7883356
[No Abstract] [Full Text] [Related]
17. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
18. [The risk of intravenous treatment with hyaluronidase from a dermatological viewpoint].
Richter G; Richter W
Dermatol Monatsschr; 1975 Nov; 161(11):952-5. PubMed ID: 1204907
[No Abstract] [Full Text] [Related]
19. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
Lukasiak B; Szczepański A; Rózański J; Wnorowski J
Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
[No Abstract] [Full Text] [Related]
20. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Nitzschner H
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
